Literature DB >> 11081193

Growth factors in pituitary tumors.

C Missale1, C Fiorentini, A Finardi, P Spano.   

Abstract

Prolactin-secreting tumors are the most frequently occurring neoplasms in the human pituitary. Although the clinical syndrome associated with prolactinomas is well recognized the molecular and cellular mechanisms leading to cell transformation and development of these tumors remain elusive. In this paper we summarize recent evidence suggesting that both hypothalamic and intrapituitary defects can be involved in the development of prolactinomas. In particular alterations of the hypothalamo-pituitary dopaminergic transmission result in the dysregulation of the proliferative activity of lactotrope cells leading to tumor development. Similarly changes in the expression and activity of resident growth factors also play a role in pituitary tumorigenesis. In particular both overexpression of TGF alpha and loss of NGF production appear to be involved in the development and progression of prolactin-secreting tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11081193     DOI: 10.1023/a:1009996712678

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  65 in total

Review 1.  Anterior pituitary development: short tales from dwarf mice.

Authors:  J W Voss; M G Rosenfeld
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

Review 2.  Nerve growth factor: from neurotrophin to neurokine.

Authors:  R Levi-Montalcini; S D Skaper; R Dal Toso; L Petrelli; A Leon
Journal:  Trends Neurosci       Date:  1996-11       Impact factor: 13.837

3.  A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally.

Authors:  H J Mangalam; V R Albert; H A Ingraham; M Kapiloff; L Wilson; C Nelson; H Elsholtz; M G Rosenfeld
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

4.  Gene transfer and molecular cloning of the rat nerve growth factor receptor.

Authors:  M J Radeke; T P Misko; C Hsu; L A Herzenberg; E M Shooter
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

5.  Epidermal growth factor stimulates thyrotropin secretion in the rat.

Authors:  L R Altschuler; M N Parisi; L F Cageao; S R Chiocchio; J A Fernandez-Pol; A A Zaninovich
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

6.  Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells.

Authors:  B C Delidow; W M Billis; P Agarwal; B A White
Journal:  Mol Endocrinol       Date:  1991-11

7.  Nerve growth factor and its receptor in the anterior pituitary.

Authors:  J C Patterson; G V Childs
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

8.  Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter.

Authors:  R Bossé; F Fumagalli; M Jaber; B Giros; R R Gainetdinov; W C Wetsel; C Missale; M G Caron
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

9.  Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas.

Authors:  J McAndrew; A J Paterson; S L Asa; K J McCarthy; J E Kudlow
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

10.  Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism.

Authors:  C Missale; F Boroni; S Sigala; A Buriani; M Fabris; A Leon; R Dal Toso; P Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more
  2 in total

Review 1.  Gene therapy for pituitary tumors.

Authors:  Adriana Seilicovich; Daniel Pisera; Sandra A Sciascia; Marianela Candolfi; Mariana Puntel; Weidong Xiong; Gabriela Jaita; Maria G Castro
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

2.  Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.

Authors:  Sergio Vidal; Eva Horvath; Luis V Syro; Humberto Uribe; Sandy Cohen; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.